By Professor Rebecca McKetin

Journal articles

Greenwood CJ; Foulds J; McKetin R; Aarsman SR; Hutchinson D; Kerr J; Heerde JA; Toumbourou JW; Boden JM; Slade T; Bonomo Y; Letcher P; Olsson CA, 2025, 'Amphetamine use and mental health difficulties across adolescence and young adulthood: An integrative data analysis of four Australasian cohort studies', Addiction, http://dx.doi.org/10.1111/add.70033

Tran AD; Chen R; Sara G; McKetin R, 2025, 'Health-care costs among people who use methamphetamine in Australia', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.14043

Reilly R; McKetin R; Barzi F; Degan T; Ezard N; Conigrave K; Butt J; Roe Y; Wand H; Quinn B; Longbottom W; Treloar C; Dunlop A; Ward J, 2025, 'Web-Based Application for Reducing Methamphetamine Use Among Aboriginal and Torres Strait Islander People: Randomized Waitlist Controlled Trial', Journal of Medical Internet Research, 27, http://dx.doi.org/10.2196/58341

Tran T; Zahra E; McKetin R; Clark B; MacPherson G; Degenhardt L, 2025, 'The Impact of Mental Health on Retention in Oat', Drug and Alcohol Dependence, 267, pp. 111995 - 111995, http://dx.doi.org/10.1016/j.drugalcdep.2024.111995

McKetin R; Degan TJ; Saunders L; Nguyen L; Dore G; Shoptaw S; Farrell M; Degenhardt L; Kelly PJ; Turner A; Clare PJ; Dean OM; Arunogiri S; Colledge-Frisby S; Koeijers J; Goodman-Meza D; Sinclair B; Reid D; Hill H; Hayllar J; Christmass M; Cordaro F; Lundin R; Liaw W; Liu D; Holyoak E; Wu BTF; Keygan J; Kontogiannis A; Palmer L; Morrison C; Wrobel A; Hyland B; Byrne M; Russell S; Zahra E; Berk M, 2024, 'A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial', Trials, 25, http://dx.doi.org/10.1186/s13063-024-08238-y

McKetin R; Clay S, 2024, 'Virtual contingency management, what is it worth and who will pay for it?', Addiction, 119, pp. 1517 - 1518, http://dx.doi.org/10.1111/add.16535

Voce A; Burns R; Castle D; Calabria B; McKetin R, 2024, 'Corrigendum to ‘Is there a discrete negative symptom dimension in people who use methamphetamine?’Comprehensive Psychiatry 93 (2019) 27–32 (Comprehensive Psychiatry (2019) 93 (27–32), (S0010440X19300252), (10.1016/j.comppsych.2019.06.002))', Comprehensive Psychiatry, 133, http://dx.doi.org/10.1016/j.comppsych.2021.152231

Clay S; Wilkinson Z; Ginley M; Arunogiri S; Christmass M; Membrey D; MacCartney P; Sutherland R; Colledge-Frisby S; Marshall AD; Nagle J; Degenhardt L; Farrell M; McKetin R, 2024, 'The reflections of health service providers on implementing contingency management for methamphetamine use disorder in Australia', Drug and Alcohol Review, 43, pp. 1313 - 1322, http://dx.doi.org/10.1111/dar.13853

Acheson LS; Clay S; McKetin R; Lintzeris N; Dunlop A; Brett J; Christmass M; Rodgers C; Shoptaw S; Farrell M; Ezard N; Siefried KJ, 2024, 'Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retention', International Journal of Drug Policy, 126, http://dx.doi.org/10.1016/j.drugpo.2024.104383

Acheson LS; Gordon C; Mcketin R; Brett J; Christmass M; Rodgers C; Lintzeris N; Dunlop A; Farrell M; Shoptaw S; Ezard N; Siefried KJ, 2024, 'Measuring Objective and Subjective Sleep during Lisdexamfetamine Treatment of Acute Methamphetamine Withdrawal: A Feasibility Study', European Addiction Research, 30, pp. 121 - 125, http://dx.doi.org/10.1159/000536328

Sivak L; Reilly R; Crumpen S; Treloar C; McKetin R; Butt J; Roe Y; Ezard N; Quinn B; Nagle J; Longbottom W; Warrior C; Ward J, 2024, 'Reducing Methamphetamine Use in Aboriginal and Torres Strait Islander Communities with the We Can Do This Web-App: Qualitative Evaluation of Acceptability and Feasibility (Preprint)', JMIR Formative Research, http://dx.doi.org/10.2196/58369

Cumming C; Kinner SA; McKetin R; Young JT; Li I; Preen DB, 2024, 'Using the Alcohol, Smoking and Substance Involvement Screening Test to predict substance-related hospitalisation after release from prison: A cohort study', Addiction (Abingdon, England), 119, pp. 236 - 247, http://dx.doi.org/10.1111/add.16365

Reuter P; McKetin R, 2024, 'Introduction to special section on precursor control', International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2024.104458

Ezard N; Clifford B; Siefried KJ; Ali R; Dunlop A; McKetin R; Bruno R; Carr A; Ward J; Farrell M; Graham R; Haber P; Lubman D; Donoghoe MW; Olsen N; Baker A; Hall M; Arunogiri S; Lintzeris N; Gill A; Rodgers C; Montebello M; Liaw W; Liu Z, 2024, 'Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial', Addiction, http://dx.doi.org/10.1111/add.16730

Sivak L; Reilly R; Lockton J; Treloar C; Roe Y; McKetin R; Butt J; Ezard N; Winkenweder H; Ward J, 2023, 'Psychosocial stress and methamphetamine use: A mixed-methods study of intersectional stigma and Aboriginal and Torres Strait Islander methamphetamine use', International Journal of Drug Policy, 121, http://dx.doi.org/10.1016/j.drugpo.2023.104189

McKetin R; Clare PJ; Castle D; Turner A; Kelly PJ; Lubman DI; Arunogiri S; Manning V; Berk M, 2023, 'How does a family history of psychosis influence the risk of methamphetamine-related psychotic symptoms: Evidence from longitudinal panel data', Addiction, 118, pp. 1975 - 1983, http://dx.doi.org/10.1111/add.16230

Bharat C; Webb P; Wilkinson Z; McKetin R; Grebely J; Farrell M; Holland A; Hickman M; Tran LT; Clark B; Peacock A; Darke S; Li JH; Degenhardt L, 2023, 'Agreement between self-reported illicit drug use and biological samples: a systematic review and meta-analysis', Addiction (Abingdon, England), 118, pp. 1624 - 1648, http://dx.doi.org/10.1111/add.16200

Clay S; Wilkinson Z; Ginley M; Arunogiri S; Christmass M; Membrey D; MacCartney P; Sutherland R; Colledge-Frisby S; Marshall AD; Nagle J; Degenhardt L; Farrell M; McKetin R, 2023, 'Perspectives and sentiments on contingency management from people who use methamphetamine', Drug and Alcohol Review, 42, pp. 1427 - 1437, http://dx.doi.org/10.1111/dar.13691

Wand H; Reilly R; McKetin R; Quinn B; Roe Y; Conigrave K; Ezard N; Butt J; Treloar C; Sivak L; Shackleford I; Dunlop A; Ward J, 2023, 'Investigating associations between methamphetamine use, mental health and risky sexual behaviours amongst Aboriginal and Torres Strait Islander peoples', Mental Health and Prevention, 30, http://dx.doi.org/10.1016/j.mhp.2023.200267

Cumming C; Kinner SA; McKetin R; Young JT; Li I; Preen DB, 2023, 'The predictive validity of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for moderate- to high-risk cannabis, methamphetamine and opioid use after release from prison', Addiction, 118, pp. 1107 - 1115, http://dx.doi.org/10.1111/add.16138

Cumming C; Kinner SA; McKetin R; Li I; Preen DB, 2023, 'The health needs of people leaving prison with a history of methamphetamine and/or opioid use', Drug and Alcohol Review, 42, pp. 778 - 784, http://dx.doi.org/10.1111/dar.13636

Carter G; Spittal MJ; Glowacki L; Gerostamoulos D; Dietze P; Sinclair B; Arunogiri S; Berk M; Lubman DI; Manning V; Higgs P; Quinn B; Baker A; Dean OM; Turner A; McKetin R, 2023, 'Diagnostic accuracy for self-reported methamphetamine use versus oral fluid test as the reference standard in a methamphetamine-dependent intervention trial population', Addiction, 118, pp. 470 - 479, http://dx.doi.org/10.1111/add.16085

Boden JM; Foulds JA; Newton-Howes G; McKetin R, 2023, 'Methamphetamine use and psychotic symptoms: Findings from a New Zealand longitudinal birth cohort', Psychological Medicine, 53, pp. 987 - 994, http://dx.doi.org/10.1017/S0033291721002415

Acheson LS; Ezard N; Lintzeris N; Dunlop A; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried KJ, 2022, 'Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial', Drug and Alcohol Dependence, 241, pp. 109692, http://dx.doi.org/10.1016/j.drugalcdep.2022.109692

Acheson LS; Ezard N; Lintzeris N; Dunlop A; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried KJ, 2022, 'Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal', PLoS ONE, 17, pp. e0275371, http://dx.doi.org/10.1371/journal.pone.0275371

Man N; Sisson SA; McKetin R; Chrzanowska A; Bruno R; Dietze PM; Price O; Degenhardt L; Gibbs D; Salom C; Peacock A, 2022, 'Trends in methamphetamine use, markets and harms in Australia, 2003–2019', Drug and Alcohol Review, 41, pp. 1041 - 1052, http://dx.doi.org/10.1111/dar.13468

Warfield SC; Bharat C; Bossarte RM; DePhilippis D; Farrell M; Hoover M; Larney S; Marshalek P; McKetin R; Degenhardt L, 2022, 'Trends in comorbid opioid and stimulant use disorders among Veterans receiving care from the Veterans Health Administration, 2005–2019', Drug and Alcohol Dependence, 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109310

Cumming C; Armstrong G; Borschmann R; Foulds JA; Newton-Howes G; McKetin R; Vallesi S; Preen D; Young J, 2022, 'Amphetamine-type stimulant use and self-harm: Protocol for a systematic review of observational studies', BMJ Open, 12, http://dx.doi.org/10.1136/bmjopen-2021-057029

Sanatkar S; Heinsch M; Tickner C; Hunt S; Teesson M; Geddes J; Gilbert J; Pedemont L; McKetin R; Kay-Lambkin F, 2022, 'A systematic literature review and narrative synthesis of effective interventions for family and caregivers of people who use methamphetamine', Substance Abuse, 43, pp. 1190 - 1196, http://dx.doi.org/10.1080/08897077.2022.2074600

Najman JM; Farrington DP; Bor W; Clavarino AM; McGee TR; Scott JG; Williams GM; McKetin R, 2022, 'Do cannabis and amphetamine use in adolescence predict adult life success: a longitudinal study', Addiction Research and Theory, 30, pp. 314 - 322, http://dx.doi.org/10.1080/16066359.2022.2032679

Acheson LS; Williams BH; Farrell M; McKetin R; Ezard N; Siefried KJ, 2022, 'Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta-analysis of randomised controlled trials', Drug and Alcohol Review, 42, http://dx.doi.org/10.1111/dar.13511

Lee WC; Fang SC; Chen YY; Liu HC; Huang MC; McKetin R, 2021, 'Exploring the mediating role of methamphetamine use in the relationship between adverse childhood experiences and attempted suicide', Addictive Behaviors, 123, http://dx.doi.org/10.1016/j.addbeh.2021.107060

Quinn B; Ward B; Agius PA; Jenkinson R; Hickman M; Sutton K; Hall C; McKetin R; Farrell M; Cossar R; Dietze PM, 2021, 'A prospective cohort of people who use methamphetamine in Melbourne and non-metropolitan Victoria, Australia: Baseline characteristics and correlates of methamphetamine dependence', Drug and Alcohol Review, 40, pp. 1239 - 1248, http://dx.doi.org/10.1111/dar.13194

McKETIN R; Quinn B; Higgs P; Berk M; Dean OM; Turner A; Kelly PJ; Lubman DI; Carter G; Baker AL; Manning V; Thomas T; Bathish R; Raftery D; Saunders L; Wrobel A; Meehan A; Sinclair B; Reid D; Arunogiri S; Hill H; Cordaro F; Dietze PM, 2021, 'Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial', Drug and Alcohol Review, 40, pp. 1249 - 1255, http://dx.doi.org/10.1111/dar.13183

Raftery D; Kelly PJ; Deane FP; Carter G; Dean OM; Lubman DI; Turner A; McKetin R, 2021, 'Cognitive insight, medication adherence and methamphetamine cessation in people enrolled in a pharmacotherapy trial for methamphetamine use', Journal of Substance Abuse Treatment, 130, http://dx.doi.org/10.1016/j.jsat.2021.108473

McKetin R; Sutherland R; Peacock A; Farrell M; Degenhardt L, 2021, 'Patterns of smoking and injecting methamphetamine and their association with health and social outcomes', Drug and Alcohol Review, 40, pp. 1256 - 1265, http://dx.doi.org/10.1111/dar.13364

McKetin R; Chrzanowska A; Man N; Peacock A; Sutherland R; Degenhardt L, 2021, 'Trends in treatment episodes for methamphetamine smoking and injecting in Australia, 2003–2019', Drug and Alcohol Review, 40, pp. 1281 - 1286, http://dx.doi.org/10.1111/dar.13258

McKetin R, 2021, 'Household surveys and the case of the Australian methamphetamine situation', Addiction, 116, pp. 2610 - 2611, http://dx.doi.org/10.1111/add.15480

McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Sinclair B; Reid D; Baker AL; Manning V; Pas NT; Thomas T; Bathish R; Raftery DK; Wrobel A; Saunders L; Arunogiri S; Cordaro F; Hill H; Hall S; Clare PJ; Mohebbi M; Berk M, 2021, 'N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial', eClinicalMedicine, 38, http://dx.doi.org/10.1016/j.eclinm.2021.101005

Hides L; Chan G; Dawe S; McKetin R; Kavanagh DJ; Young RMD; Teesson M; Saunders JB, 2021, 'Direction of the relationship between methamphetamine use and positive psychotic symptoms in regular methamphetamine users: Evidence from a prospective cohort study', British Journal of Psychiatry, 219, pp. 361 - 367, http://dx.doi.org/10.1192/bjp.2019.263

Voce A; Burns R; Castle D; Calabria B; McKetin R, 2021, 'A latent class analysis of psychiatric symptom profiles associated with past-month methamphetamine use', Psychiatry Research, 298, http://dx.doi.org/10.1016/j.psychres.2021.113760

McKetin R; Farrell M, 2021, 'When the evidence is not enough: is it time to rethink trial design?', Addiction, 116, pp. 711 - 712, http://dx.doi.org/10.1111/add.15273

Raftery D; Kelly PJ; Deane FP; Baker AL; Ingram I; Goh MCW; Lubman DI; Carter G; Turner A; Dean OM; Sinclair BL; McKetin R, 2020, 'Insight in substance use disorder: A systematic review of the literature', Addictive Behaviors, 111, http://dx.doi.org/10.1016/j.addbeh.2020.106549

McKetin R; Boden JM; Foulds JA; Najman JM; Ali R; Degenhardt L; Baker AL; Ross J; Farrell M; Weatherburn D, 2020, 'The contribution of methamphetamine use to crime: Evidence from Australian longitudinal data', Drug and Alcohol Dependence, 216, pp. 108262, http://dx.doi.org/10.1016/j.drugalcdep.2020.108262

Reilly R; Wand H; McKetin R; Quinn B; Ezard N; Dunlop A; Conigrave K; Treloar C; Roe Y; Gray D; Stephens J; Ward J, 2020, 'Survey methods and characteristics of a sample of Aboriginal and Torres Strait Islander and non-Indigenous people who have recently used methamphetamine: the NIMAC survey', Drug and Alcohol Review, 39, pp. 646 - 655, http://dx.doi.org/10.1111/dar.13085

McKetin R; Voce A; Burns RA; Quinn B, 2020, 'The Short Barriers Questionnaire (SBQ): Validity, factor structure and correlates in an out-of-treatment sample of people dependent on methamphetamine', Journal of Substance Abuse Treatment, 116, http://dx.doi.org/10.1016/j.jsat.2020.108029

Cumming C; Kinner SA; McKetin R; Li I; Preen D, 2020, 'Methamphetamine use, health and criminal justice system outcomes: A systematic review', Drug and Alcohol Review, 39, pp. 505 - 518, http://dx.doi.org/10.1111/dar.13062

Bórquez A; Rich K; Farrell M; Degenhardt L; McKetin R; Tran LT; Cepeda J; Silva-Santisteban A; Konda K; Cáceres CF; Kelly S; Altice FL; Martin NK, 2020, 'Integrating HIV pre-exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study', Journal of the International AIDS Society, 23, http://dx.doi.org/10.1002/jia2.25495

Kelly PJ; Baker AL; Fagan NL; Turner A; Deane F; McKetin R; Callister R; Collins C; Ingram I; Wolstencroft K; Townsend C; Osborne BA; Zimmermann A, 2020, 'Better Health Choices: Feasability and preliminary effectiveness of a peer delivered healthy lifestyle intervention in a community mental health setting', Addictive Behaviors, 103, http://dx.doi.org/10.1016/j.addbeh.2019.106249

Arunogiri S; McKetin R, 2020, 'Comment on Zang et al 2019: The importance of distinguishing between psychotic and general psychiatric symptoms in the context of methamphetamine use', Addiction Biology, 25, http://dx.doi.org/10.1111/adb.12776

Back to profile page